Ignite Creation Date:
2025-12-24 @ 10:49 PM
Ignite Modification Date:
2026-02-20 @ 4:46 PM
Study NCT ID:
NCT02385669
Status:
TERMINATED
Last Update Posted:
2020-05-05
First Post:
2015-03-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma
Sponsor:
Craig L Slingluff, Jr
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
17780
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None